ImmuCell Corporation Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year
ImmuCell Corporation (ICCC) had Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year of $19.10 thousand as of 2019-12-31, per its 10-K filed 2020-03-27.
Discontinued › Notes › Goodwill and Other › Intangible Asset, Finite-Lived, and Capitalized Cost, Software to be Sold, Leased, or Marketed, Estimated Amortization Expense
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear · last filed 2020-03-27
- 2019-12-31: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $19.10K.
- 2019-09-30: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $4.78K.
- 2019-06-30: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $9.55K.
- 2019-03-31: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $14.33K.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year |
|---|---|
| 2019-12-31 | $19.10K 10-K · filed 2020-03-27 |
| 2019-09-30 | $4.78K 10-Q · filed 2019-11-12 |
| 2019-06-30 | $9.55K 10-Q · filed 2019-08-12 |
| 2019-03-31 | $14.33K 10-Q · filed 2019-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |